Published on : Jul 20, 2017
Albany, New York, July 20, 2017: In recent years, the prevalence of end-stage renal disease, which is the most advanced stage of kidney disease has been increased. One of the best treatments includes kidney transplant or dialysis with dietary management. It has been analyzed that, more than 500,000 individuals currently are being treated for kidney failure via dialysis or kidney transplant, which as a result boosting the therapeutic market of end-stage renal disease. Market Research Hub (MRH) has freshly added a forecast study to its vast archive, which is titled as “Global End Stage Renal Disease (ESRD) Market with Focus on Dialysis Market (2017-2021 Edition)”. In this study, projections are made that the market would rise in the next five years i.e. 2017-2021 enormously.
End stage renal disease (ESRD) occurs when chronic kidney disease worsens to the point at which kidney function is less than 10% of normal. ESRD leads to buildup of waste products and fluid in the body, which affects most body systems and functions, including, blood pressure control, red blood cell production, vitamin D and calcium levels and thus affect bone health. As far as treatment is concerned, dialysis or a kidney transplant are the only treatments for late-stage kidney disease.
For better understanding of the market, the report includes country analysis of the US and Japan for ESRD market. It has been identified that more than 661,000 Americans have kidney failure. Among these, 468,000 individuals are on dialysis, and other live with a functioning kidney transplant. The report also provides market size of each of the segments of the market on the basis of the treatment opted by the patients along with the detailed overview of the home dialysis market. Detailed regional analysis of Asia-Pacific, North America, EMEA and Latin America for the dialysis market has been presented which includes market size by volume along with the segments and clinic operators in each region.
Moreover, this research study provides an in-depth analysis of the global ESRD market with comprehensive analysis of market size and growth, market share and economic impact of the industry during the forecast period of 2017 to 2021. The expected growth of the overall global ESRD market has also been estimated for the period 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current & future trends. During the years 2011 to 2016, the global ESRD market increased at a significant CAGR. This upsurge in the market was due to the various reasons such as is diabetic nephropathy, genetic diseases, infection, drugs, traumatic injury, major surgery, etc. Some of the prime growth drivers are rise in diabetic and aging population, upsurge in per capita healthcare expenditure along with the emerging countries such as India, China and Brazil.
Further, the study highlights key players operating in the global market, such as Fresenius Medical Care, Davita and Baxter.
Click here to get more info with TOC in a PDF Format : http://www.marketresearchhub.com/enquiry.php?type=S&repid=1221341
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org